Floatz logo

Iron Hydroxide Polymaltose

Iron Deficiency Anemia

Kaplan Medical CenterUNKNOWNPhase 3Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Iron Deficiency Anemia cohort.

Asset / SponsorPhaseRating
Ferric Cation
Fundación para la Investigación del Hospital Clínico de Valencia
Phase 4A
Iron Isomaltoside
China-Japan Friendship Hospital
Phase 4BBB
Iron(Ii) Sulphate (1:1), Heptahydrate
Linda Malan
Phase 4BBB
SODIUM FERRIC GLUCONATE
Watson Pharmaceuticals
Phase 4BBB
Iron
Cairo University
Phase 4BB

View all 13 →

Same molecule, other indications

Iron Hydroxide Polymaltose is also rated in:

celiac diseaseActive
NR
Indicative · N/A
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →